About the Authors
- Cecilia S. Lindestam Arlehamn
-
* E-mail: cecilia@lji.org
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
- Denise M. McKinney
-
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
- Chelsea Carpenter
-
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
- Sinu Paul
-
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
- Virginie Rozot
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Edward Makgotlho
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Yolande Gregg
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Michele van Rooyen
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Joel D. Ernst
-
Affiliation Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, New York, United States of America
- Mark Hatherill
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Willem A. Hanekom
-
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Bjoern Peters
-
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
- Thomas J. Scriba
-
¶‡ These authors are joint senior authors on this work.
Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- Alessandro Sette
-
¶‡ These authors are joint senior authors on this work.
Affiliation La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: CSLA DMM AS TJS WAH VR BP. Performed the experiments: CSLA CC DMM. Analyzed the data: CSLA CC DMM SP. Contributed reagents/materials/analysis tools: VR EM YG MvR SP MH WAH TJS JDE. Wrote the paper: CSLA VR TJS AS BP.